A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer

Title
A Phase II Trial of Selinexor (KPT‐330) for Metastatic Triple‐Negative Breast Cancer
Authors
Keywords
-
Journal
ONCOLOGIST
Volume -, Issue -, Pages theoncologist.2019-0231
Publisher
Alphamed Press
Online
2019-04-18
DOI
10.1634/theoncologist.2019-0231

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now